Business Description
Newbury Pharmaceuticals AB
ISIN : SE0015244884
Compare
Compare
Traded in other countries / regions
NEWBRY.SwedenP52.Germany IPO Date
2022-02-04Description
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.49 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.76 | |||||
Beneish M-Score | -0.54 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.76 | |||||
9-Day RSI | 55.17 | |||||
14-Day RSI | 53.53 | |||||
6-1 Month Momentum % | -7.26 | |||||
12-1 Month Momentum % | -20.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 92.14 | |||||
Days Sales Outstanding | 145.84 | |||||
Days Payable | 117.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.73 | |||||
Operating Margin % | -62.61 | |||||
Net Margin % | -75.93 | |||||
FCF Margin % | -113.1 | |||||
ROE % | -34.87 | |||||
ROA % | -21.48 | |||||
ROIC % | -21.45 | |||||
ROCE % | -25.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.92 | |||||
PB Ratio | 1.63 | |||||
EV-to-EBIT | -4.49 | |||||
EV-to-EBITDA | -4.91 | |||||
EV-to-Revenue | 3.24 | |||||
EV-to-FCF | -2.78 | |||||
Earnings Yield (Greenblatt) % | -22.28 | |||||
FCF Yield % | -32.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Newbury Pharmaceuticals AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 22.827 | ||
EPS (TTM) (kr) | -0.889 | ||
Beta | 0 | ||
Volatility % | 76.57 | ||
14-Day RSI | 53.53 | ||
14-Day ATR (kr) | 0.203843 | ||
20-Day SMA (kr) | 3.282 | ||
12-1 Month Momentum % | -20.33 | ||
52-Week Range (kr) | 2.4 - 6.24 | ||
Shares Outstanding (Mil) | 24.26 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Newbury Pharmaceuticals AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Newbury Pharmaceuticals AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Newbury Pharmaceuticals AB Frequently Asked Questions
What is Newbury Pharmaceuticals AB(OSTO:NEWBRY)'s stock price today?
The current price of OSTO:NEWBRY is kr3.32. The 52 week high of OSTO:NEWBRY is kr6.24 and 52 week low is kr2.40.
When is next earnings date of Newbury Pharmaceuticals AB(OSTO:NEWBRY)?
The next earnings date of Newbury Pharmaceuticals AB(OSTO:NEWBRY) is 2024-07-10.
Does Newbury Pharmaceuticals AB(OSTO:NEWBRY) pay dividends? If so, how much?
Newbury Pharmaceuticals AB(OSTO:NEWBRY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |